Literature DB >> 14777528

[Active principals of the cannabis and the pharmacology of the cannabinols].

S LOEWE.   

Abstract

Entities:  

Keywords:  CANNABIS

Mesh:

Substances:

Year:  1950        PMID: 14777528

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol


× No keyword cloud information.
  12 in total

1.  The effect of cannabinol delta1-tetrahydro-cannabinol clearance from the blood.

Authors:  N K McCallum
Journal:  Experientia       Date:  1975-08-15

2.  [Co-editors and editors with Jewish origins of the first German journals for anaesthesia. Their fate under National Socialism and an attempt at a biographical appreciation].

Authors:  M Goerig; A E Goetz
Journal:  Anaesthesist       Date:  2010-09       Impact factor: 1.041

3.  Tetrahydrocannabinols.

Authors: 
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  Equidistance concept and structure-activity relationship of curarizing drugs.

Authors:  S LOEWE; S C HARVEY
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1952

Review 5.  New approaches and challenges to targeting the endocannabinoid system.

Authors:  Vincenzo Di Marzo
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

6.  Cannabinoids and hexobarbital induced loss of righting reflexes.

Authors:  M Fernandes; S Kluwe; H Coper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  [Hashish--chemistry and problems].

Authors:  D Bieniek; W Gau; F Korte
Journal:  Naturwissenschaften       Date:  1974-03

8.  Lack of tolerance to the effect of two tetrahydrocannabinols on aggressiveness.

Authors:  M ten Ham; J van Noordwijk
Journal:  Psychopharmacologia       Date:  1973-03-16

Review 9.  Are biogenic amines involved in the mechanism of action of the tetrahydrocannabinols?

Authors:  R Dagirmanjian; H C Hodge
Journal:  Agents Actions       Date:  1969-11

Review 10.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.